Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the mass balance, absorption, metabolism, and
elimination pathways of orally administered [14C] rucaparib followed by cycle by cycle
treatment with rucaparib continuing until disease progression or other reason for
discontinuation